Download PDF
Der Klinikarzt 2004; 33(11): 303-307
DOI: 10.1055/s-2004-837042
Kardiologie

© Georg Thieme Verlag Stuttgart · New York

Koronare Herzkrankheit und Frauen - Geschlechtsspezifische Unterschiede werden häufig unterschätzt

Cardiovascular Disease and Women - Gender Specific Differences are Commonly UnderestimatedChr. M. Schannwell1
  • 1Klinik für Kardiologie, Pneumologie und Angiologie, Heinrich-Heine-Universitätsklinikum Düsseldorf (Direktor: Prof. Dr. B.E. Strauer)
Further Information

Publication History

Publication Date:
02 December 2004 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Kardiovaskuläre Erkrankungen sind die häufigste Todesursache bei Frauen und Männern in den Industrieländern. Trotz zunehmender Morbidität und Mortalität wird bei Frauen die koronare Herzkrankheit klinisch noch immer unterschätzt. Auch wenn ihre Inzidenz mit zunehmendem Alter bei Frauen zunimmt, tritt die klinische Manifestation einer koronaren Herzkrankheit im Durchschnitt zehn Jahre später auf als bei Männern. Unglücklicherweise sind die in der Routine eingesetzten nichtinvasiven Screeningverfahren für das Vorhandensein einer koronaren Herzkrankheit nicht sehr sensitiv und eher unspezifisch für Frauen. Allerdings ermöglichen die neuen Entwicklungen in der Katheter- und Stenttechnik, der adjuvanten medikamentösen Therapien und der chirurgischen Techniken sichere und effektive Koronarinterventionen bei Frauen und Männern.

Summary

Cardiovascular disease remains the leading cause of mortality for women and men in developed countries. Although coronary artery disease is the major cause of morbidity and mortality in women, coronary heart disease in women is still clinically underestimated. Although the incidence of coronary heart disease increases with age in women, the clinical presentation of the disease lags ten years behind that in men. Unfortunately, the routinely available non-invasive tests used to screen the presence of coronary artery disease have been relatively insensitive and nonspecific for women. However, recent advances in device application, adjunctive therapies and surgical techniques suggest that coronary revasculation strategies are safe and effective for women and men.

Key Words

cardiovascular desease - women - screening - stents - revasculation strategies

Literatur

  • 1 Boersma E, Maas A, Deckers J, Simoons M. Early thrombolytic treatment in acute MI: reappraisal of the golden hour.  Lancet. 1996;  348 771-775
    CrossrefPubMedSearch in Google Scholar
  • 2 Brochier ML, Arwidson P. Coronary heart disease risk factors in women.  Eur Heart J. 1998;  19 A45-A52
    PubMedSearch in Google Scholar
  • 3 Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X.  Circulation. 1992;  85 883-892
    CrossrefPubMedSearch in Google Scholar
  • 4 Castelli W. Epidemiology of coronary heart disease, Framingham Study.  Am J Med. 1984;  76 4-12
    CrossrefPubMedSearch in Google Scholar
  • 5 Cox ID, Schwartzman RA, Atienza F. et al. . Angiographic progression in patients with angina pectoris and normal or near normal coronary angiograms who are restudied due to unstable symptoms.  Eur Heart J. 1998;  19 1027-1033
    CrossrefPubMedSearch in Google Scholar
  • 6 De Sanctis RW. Clinical manifestations of coronary artery disease: Chest pain in women. In: Wenger NK, Speroff L, Packard B (eds). Cardiovascular health and disease in women. Greewich/CT: Le Jacq Communications
  • 7 Detry JR, Kapita BM, Cosyns J. et al. . Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease.  Circulation. 1977;  56 756-761
    PubMedSearch in Google Scholar
  • 8 Douglas PS, Ginsburg GS. The evaluation of chest pain in women.  N Engl J Med. 1996;  334 1311-1315
    CrossrefPubMedSearch in Google Scholar
  • 9 Friedman TD, Greene AC, Iskandrian AS. et al. . Exercise thallium-201 myocardial scintigraphy in women: correlation with coronary arteriography.  Am J Cardiol. 1982;  49 1632-1637
    CrossrefPubMedSearch in Google Scholar
  • 10 FRISC II prospective randomised multicentre study . Invasive compared with non-invasive treatment in unstable coronary artery disease. Fragmin and Fast Revascularisation during Instability in Coronary Artery disease Investigators.  Lancet. 1994;  354 708-715
    PubMedSearch in Google Scholar
  • 11 Grady D, Rubin S, Petitti DB. et al. . Hormone therapy to prevent disease and prolong life in postmenopausal women.  Ann Intern Med. 1992;  117 1016-1037
    PubMedSearch in Google Scholar
  • 12 Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men.  Circulation. 1991;  83 484-491
    PubMedSearch in Google Scholar
  • 13 Grines CL, Browne KF, Marco J. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Study Group.  N Engl J Med. 1993;  328 673-679
    CrossrefPubMedSearch in Google Scholar
  • 14 Gurwitz JH, Mc TJ Laughlin, Willison DJ. Delayed hospital presentation in patients who have had acute myocardial infarction.  Ann Intern Med. 1997;  126 593-599
    PubMedSearch in Google Scholar
  • 15 Hulley S, Grady D, Bush T. et al. . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease on postmenopausal women.  JAMA. 1998;  280 605-613
    CrossrefPubMedSearch in Google Scholar
  • 16 Jacobs AK, Kelsey SF, Brooks MM. et al. . Better outcome for women compared with men undergoing coronary revascularization A report from the bypass angioplasty revascularization investigation (BARI).  Circulation. 1998;  98 1279-1285
    PubMedSearch in Google Scholar
  • 17 Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage.  Arch Intern Med. 1995;  155 57-61
    CrossrefPubMedSearch in Google Scholar
  • 18 Kornowski R, Goldbourt U, Boyko V, Behar S. Clinical predictors of reinfarction among men and women after a first myocardial infarction. Secondary Prevention Israeli Reinfarction Nifedipine Trial (SPRINT) Study Group.  Cardiology. 1995;  86 163-168
    PubMedSearch in Google Scholar
  • 19 Lewis SJ, Sacks FM, Mitchell JS. et al. . Effect of pravastatin on cardiovascular events in women after myocardial infarction. The Cholesterol And Recurrent Events (CARE) Trial.  J Am Coll Cardiol. 1998;  32 140-146
    CrossrefPubMedSearch in Google Scholar
  • 20 Lincoff AM, Califf RM, Ellis SG. et al. . Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.  J Am Coll Cardiol. 1993;  22 1780-1787
    PubMedSearch in Google Scholar
  • 21 Löwel H, Lewis M, Keil U. et al. . Zeitliche Trends von Herzinfarktmorbidität, -mortalität, 28-Tage-Letalität und medizinischer Versorgung. Ergebnisse des Augsburger Herzinfarktregisters von 1985 bis 1992.  Z Kardiol. 1995;  84 596-605
    PubMedSearch in Google Scholar
  • 22 Marwick TH, Anderson T, Williams MJ. et al. . Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women.  J Am Coll Cardiol. 1995;  26 335
    CrossrefPubMedSearch in Google Scholar
  • 23 Merz CNB, Kelsey SF, Pepine CJ. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report.  J Am Coll Cardiol. 1999;  33 1453-1461
    CrossrefPubMedSearch in Google Scholar
  • 24 Rodda BE. The Timolol Myocardial Infarction Study; an evaluation of selected variables.  Circulation. 1983;  67 1101-1106
    PubMedSearch in Google Scholar
  • 25 Schannwell CM, Lazica D, Plehn G. et al. . Stellenwert der nichtinvasiven kardialen Diagnostik bei Frauen mit Verdacht auf koronare Herzerkrankheit.  Med Klinik. 2002;  97 513-521
    PubMedSearch in Google Scholar
  • 26 Schannwell CM, Schoebel FC, Lazica D. et al. . Besonderheiten der koronaren Herzkrankheit in der klinischen Symptomatik und Erstdiagnostik bei Frauen.  Dtsch med Wschr. 2000;  125 1417-1423
    Thieme ConnectPubMedSearch in Google Scholar
  • 27 Schenck-Gustafsson K. Risk factors for cardiovascular disease in women: assessment and management.  Eur Heart J. 1996;  17 2-8
    PubMedSearch in Google Scholar
  • 28 Shaw LJ, Miller DD, Romeis JC. et al. . Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease.  Ann Intern Med. 1994;  120 559-566
    PubMedSearch in Google Scholar
  • 29 The TIMI III B Investigators . Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non Q wave myocardial infarction. Results of TIMI III B Trial.  Circulation. 1994;  89 1545-1556
    PubMedSearch in Google Scholar
  • 30 van der Lohe E. Koronare Herzkrankheit bei Frauen. Berlin, Heidelberg, New York, Barcelona,Hongkong, London, Mailand, Paris, Tokio: Springer 2002: 51-150
    Search in Google Scholar
  • 31 Weaver WD, White HD, Wilcox RG. et al. . Comparison of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I Investigators.  JAMA. 1996;  275 777-782
    CrossrefPubMedSearch in Google Scholar
  • 32 Weintraub WS, King III SB, Jones EL. Comparison of coronary surgery and PTCA in patients with two vessel coronary disease.  Am J Cardiol. 1993;  71 511-517
    CrossrefPubMedSearch in Google Scholar

1 secondary prevention reinfarction israeli nifedipine trial

2 primary angioplasty in myocardial infarction

3 global utilization of streptokinase and t-PA for occluded coronary arteries

4 MIDA

5 prehospital-initiated versus hospital-initiated thrombolytic therapy

6 survival and ventricular enlargement

7 fragmin and fast revascularisation during instability in coronary artery disease

8 cholesterol and recurrent events

9 second international study of infarct survival

10 heart and estrogen/progestin replacement study

11 bypass angioplasty revascularization investigation

Anschrift der Verfasserin

PD Dr. Dr. Christiana Mira Schannwell

Oberärztin der Medizinischen Klinik und Poliklinik B

Klinik für Kardiologie, Pneumologie und Angiologie

Heinrich-Heine-Universität Düsseldorf

Moorenstr. 5

40225 Düsseldorf